Mary Beth Springer - 11 Feb 2026 Form 4 Insider Report for CENTRAL GARDEN & PET CO (CENT)

Role
Director
Signature
/s/Filomena Eickstaedt as Attorney-in-Fact for Mary Beth Springer
Issuer symbol
CENT
Transactions as of
11 Feb 2026
Net transactions value
-$27.08
Form type
4
Filing time
12 Feb 2026, 17:52:40 UTC
Previous filing
14 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SPRINGER MARY BETH Director C/O CENTRAL GARDEN & PET COMPANY, 1340 TREAT BLVD, SUITE 600, WALNUT CREEK /s/Filomena Eickstaedt as Attorney-in-Fact for Mary Beth Springer 12 Feb 2026 0001203228

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CENT Class A Common Stock Options Exercise $200,004 +8,803 +44% $22.72 28,995 11 Feb 2026 Direct F1
transaction CENT Class A Common Stock Tax liability $200,031 -5,948 -21% $33.63 23,047 11 Feb 2026 Direct F2
transaction CENT Class A Common Stock Award $0 +3,584 +16% $0.000000 26,631 11 Feb 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CENT Stock Option (Right to Buy) Options Exercise $0 -8,803 -100% $0.000000 0 11 Feb 2026 Class A Common Stock 8,803 $22.72 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 7, 2023, Company declared a stock dividend, payable to all holders on record of Common Stock and Class A Common Stock as of January 8, 2024, of one share of Class A Common Stock for every four shares of Common Stock and Class A Common Stock outstanding. At the same time, pursuant to anti-dilution provisions, an option for 7,043 shares Class A Common Stock on January 8, 2024 became exercisable for 8,803 shares of Class A Common Stock.
F2 Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise.
F3 Restricted stock award granted under the Company's Nonemployee Director Equity Incentive Plan, as amended.
F4 This option was previously reported as an option for 7,043 shares of Class A Common Stock at an exercise price of $28.40 per share, but was adjusted to reflect the stock dividend declared by Company on December 7, 2023. As a result of the stock dividend, the option also entitled the Reporting Person to receive, upon exercise, 1,760 shares of Class A Common Stock for no additional consideration.
F5 Options were granted on February 11, 2020, and all shares are vested and have been exercised.

Remarks:

Exhibit 24.1; Power of Attorney